OptiNose Q1 EPS $(0.12) Misses $(0.11) Estimate, Sales $14.88M Beat $12.94M Estimate
Portfolio Pulse from Benzinga Newsdesk
OptiNose reported Q1 EPS of $(0.12), missing the $(0.11) estimate, but its sales of $14.88M exceeded the $12.94M forecast. This represents a 29.41% increase in losses and a 25.61% increase in sales from the same period last year.
May 14, 2024 | 11:03 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OptiNose missed EPS estimates but exceeded revenue forecasts in Q1, showing significant sales growth compared to last year.
While the EPS miss might concern some investors, the significant beat on revenue forecasts and the year-over-year sales growth could offset negative sentiment. The mixed results present a neutral short-term outlook as the revenue growth indicates potential upside, but the EPS miss could temper immediate gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100